Compliance to Performance

In-Person

London, United Kingdom

Course Overview

NSF will host its second Pharma Biotech conference on 14 November at The Royal Society of Chemistry in London.

We will be welcoming a range of speakers from industry, regulatory bodies, and industry associations. Speakers include:

Christopher Davenport – AstraZeneca

Lynne Ensor – NSF

Paul Fleming – British Generic Manufacturers Association/British Biosimilars Association

Dr Peter Gough – NSF

Dr Richard Greville – Association of the British Pharmaceutical Industry

Emilija Matelyté - The European Medicines Agency

Liam Rogers – NSF

Bruce Warner - RPS and Former Deputy Chief Pharmaceutical Officer for England

Ian Jackson - MHRA

The two themes for the one-day event are artificial intelligence (AI) and the technological advancements in manufacturing and supply chain shortages and resilience.

09.00-10.00 Registration, Coffee, and Networking

Morning Session 1

In this initial session Pete Gough will provide a comprehensive regulatory update, with a focus on our two conference themes. Following this we will hear from industry experts about their experiences of AI and technology advancements, with real life examples and thought-provoking initiatives that will keep the discussions flowing throughout the networking break.

Networking Break

Morning Session 2

The second morning session will focus on the impact of artificial intelligence and how it, and other technologies, are shaping regulation and activities across the pharma biotech sector.

Christopher Davenport from AstraZeneca will look at how the industry has responded to the breakneck speed of developments in recent years. Liam Rogers from NSF will look at the issue from his perspective of working with our clients across clinical, medical device, and pharma biotech, and consider how the technology is being adopted.

Networking Lunch for delegates and speakers

Afternoon Session 1

The afternoon session focuses on the issue of supply chain. The past 5 years have brought this topic onto the front page of newspapers and TV news bulletins. The issue of supply chain resilience is of critical importance to the pharma biotech sector.

Emilija Matelyté from The European Medicines Agency will be joined by Bruce Warner to look at issues around supply and availability from a European perspective.

The afternoon session will also hear from two of the most respected names in pharma biotech industry associations. Both Paul Fleming and Dr Richard Greville will discuss how companies are dealing with disruption and building resilience into their supply chains.

The day will end with a questions and answers session between guests and speakers. Last year’s event had a vibrant questions and answers session and the 2024 event is sure to spark several topics for delegates and speakers to consider.

16.30 Closing Remarks from Lynne Ensor.

You can purchase a ticket to attend by clicking the register button below or at the top of this page.

Additional Recommended Courses

Pharmaceutical Law and Administration
York, United Kingdom
GMP PQS Lead Auditor (CQI & IRCA Certified Training)
York, United Kingdom
Pharmaceutical Quality Systems
York, United Kingdom